These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 23470074)

  • 21. Serum myeloperoxidase levels independently predict endothelial dysfunction in humans.
    Vita JA; Brennan ML; Gokce N; Mann SA; Goormastic M; Shishehbor MH; Penn MS; Keaney JF; Hazen SL
    Circulation; 2004 Aug; 110(9):1134-9. PubMed ID: 15326065
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hemostasis, endothelial stress, inflammation, and the metabolic syndrome.
    Grandl G; Wolfrum C
    Semin Immunopathol; 2018 Feb; 40(2):215-224. PubMed ID: 29209827
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of myeloperoxidase with total and cardiovascular mortality in individuals undergoing coronary angiography--the LURIC study.
    Scharnagl H; Kleber ME; Genser B; Kickmaier S; Renner W; Weihrauch G; Grammer T; Rossmann C; Winkelmann BR; Boehm BO; Sattler W; März W; Malle E
    Int J Cardiol; 2014 Jun; 174(1):96-105. PubMed ID: 24746542
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased plasma soluble tumor necrosis factor receptor-1 and myeloperoxidase activity in patients with obstructive sleep apnea syndrome.
    Hanikoglu F; Huseyinoglu N; Ozben S; Cort A; Ozdem S; Ozben T
    Int J Neurosci; 2015; 125(9):655-62. PubMed ID: 25180986
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The impact of myeloperoxidase on HDL function in myocardial infarction.
    Tietge UJF
    Curr Opin Endocrinol Diabetes Obes; 2018 Apr; 25(2):137-142. PubMed ID: 29356689
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Myeloperoxidase and Neurological Disorder: A Crosstalk.
    Pravalika K; Sarmah D; Kaur H; Wanve M; Saraf J; Kalia K; Borah A; Yavagal DR; Dave KR; Bhattacharya P
    ACS Chem Neurosci; 2018 Mar; 9(3):421-430. PubMed ID: 29351721
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Myeloperoxidase in cardiovascular disease.
    Koeth RA; Haselden V; Tang WH
    Adv Clin Chem; 2013; 62():1-32. PubMed ID: 24772664
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Myeloperoxidase: a target for new drug development?
    Malle E; Furtmüller PG; Sattler W; Obinger C
    Br J Pharmacol; 2007 Nov; 152(6):838-54. PubMed ID: 17592500
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Arterial myeloperoxidase in the detection and treatment of vulnerable atherosclerotic plaque: a new dawn for an old light.
    Nadel J; Jabbour A; Stocker R
    Cardiovasc Res; 2023 Mar; 119(1):112-120. PubMed ID: 35587708
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of a short-term diet and exercise intervention on oxidative stress, inflammation, MMP-9, and monocyte chemotactic activity in men with metabolic syndrome factors.
    Roberts CK; Won D; Pruthi S; Kurtovic S; Sindhu RK; Vaziri ND; Barnard RJ
    J Appl Physiol (1985); 2006 May; 100(5):1657-65. PubMed ID: 16357066
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum myeloperoxidase and mortality in maintenance hemodialysis patients.
    Kalantar-Zadeh K; Brennan ML; Hazen SL
    Am J Kidney Dis; 2006 Jul; 48(1):59-68. PubMed ID: 16797387
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Myeloperoxidase and cardiovascular disease.
    Nicholls SJ; Hazen SL
    Arterioscler Thromb Vasc Biol; 2005 Jun; 25(6):1102-11. PubMed ID: 15790935
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of oxidative stress, antioxidants and vascular inflammation in cardiovascular disease (a review).
    Siti HN; Kamisah Y; Kamsiah J
    Vascul Pharmacol; 2015 Aug; 71():40-56. PubMed ID: 25869516
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oxidative stress and vascular inflammation in aging.
    El Assar M; Angulo J; Rodríguez-Mañas L
    Free Radic Biol Med; 2013 Dec; 65():380-401. PubMed ID: 23851032
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neutrophil-derived myeloperoxidase promotes atherogenesis and neointima formation in mice.
    Tiyerili V; Camara B; Becher MU; Schrickel JW; Lütjohann D; Mollenhauer M; Baldus S; Nickenig G; Andrié RP
    Int J Cardiol; 2016 Feb; 204():29-36. PubMed ID: 26655530
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interactions between NO and reactive oxygen species: pathophysiological importance in atherosclerosis, hypertension, diabetes and heart failure.
    Kojda G; Harrison D
    Cardiovasc Res; 1999 Aug; 43(3):562-71. PubMed ID: 10690328
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pulmonary oxidative stress, inflammation, and dysregulated iron homeostasis in rat models of cardiovascular disease.
    Shannahan JH; Schladweiler MC; Richards JH; Ledbetter AD; Ghio AJ; Kodavanti UP
    J Toxicol Environ Health A; 2010; 73(10):641-56. PubMed ID: 20391109
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic value of myeloperoxidase concentration in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention.
    Kacprzak M; Zielinska M
    Int J Cardiol; 2016 Nov; 223():452-457. PubMed ID: 27544604
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Leukocyte-derived myeloperoxidase amplifies high-glucose--induced endothelial dysfunction through interaction with high-glucose--stimulated, vascular non--leukocyte-derived reactive oxygen species.
    Zhang C; Yang J; Jennings LK
    Diabetes; 2004 Nov; 53(11):2950-9. PubMed ID: 15504976
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Myeloperoxidase: molecular mechanisms of action and their relevance to human health and disease.
    van der Veen BS; de Winther MP; Heeringa P
    Antioxid Redox Signal; 2009 Nov; 11(11):2899-937. PubMed ID: 19622015
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.